Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
When the parts of the ear that transmit sound to the auditory nerve are damaged—as they often are in the severely deaf—a hearing aid that merely amplifies sound offers little assistance. Today, more ...
The FDA has approved hearing implant maker Cochlear Limited’s submission for a new remote feature that would allow specialists to perform follow-up programming on a patient’s cochlear implant remotely ...
WEYBRIDGE, United Kingdom--(BUSINESS WIRE)--Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has today announced the release of the Nucleus ® Smart App for Android ™, ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Cochlear Limited is ...
Sensorion (FR0012596468 – ALSEN) a biotech company pioneering novel treatments for inner ear diseases, and Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today ...
Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results